Senna With Docusate Sodium Tablet
Product Images NDC 83586-001

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Senna With Docusate Sodium (NDC 83586-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hhh Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label)

This is a description for "SENNA WITH DOCUSATE SODIUM TABLETS". The medication contains Calcium Sennosides USP 8.6 mg and Docusate Sodium USP 50 mg. It is advised to keep the tablets out of children's reach and store at a controlled room temperature of 15° - 30°C, protected from light, moisture, and freezing. The batch needs to be repacked before a specified date and is intended for further processing. The tablets come in a bulk shipment that should be approved, repackaged within 9 months from the manufacturing date, and labeled in conformance with FDA regulations. The product is from Elysium Pharmaceuticals Ltd. and HH Pharma USA LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.